BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10949653)

  • 41. [The signal transduction of receptor tyrosine kinase].
    Takada T; Matozaki T; Kasuga M
    Nihon Rinsho; 1998 Jul; 56(7):1756-62. PubMed ID: 9702050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta.
    Holland SJ; Peles E; Pawson T; Schlessinger J
    Curr Opin Neurobiol; 1998 Feb; 8(1):117-27. PubMed ID: 9568399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
    Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of phosphorylated proteins associated with the fibroblast growth factor receptor type I during early Xenopus development.
    Ryan PJ; Paterno GD; Gillespie LL
    Biochem Biophys Res Commun; 1998 Mar; 244(3):763-7. PubMed ID: 9535739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival.
    Pazdrak K; Adachi T; Alam R
    J Exp Med; 1997 Aug; 186(4):561-8. PubMed ID: 9254654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development.
    Puri MC; Partanen J; Rossant J; Bernstein A
    Development; 1999 Oct; 126(20):4569-80. PubMed ID: 10498691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tie receptors: new modulators of angiogenic and lymphangiogenic responses.
    Jones N; Iljin K; Dumont DJ; Alitalo K
    Nat Rev Mol Cell Biol; 2001 Apr; 2(4):257-67. PubMed ID: 11283723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
    He HY; Zheng J; Li Y; Heng WJ; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2.
    Gadina M; Sudarshan C; O'Shea JJ
    J Immunol; 1999 Feb; 162(4):2081-6. PubMed ID: 9973481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vascular endothelial growth factor receptor-3.
    Taipale J; Makinen T; Arighi E; Kukk E; Karkkainen M; Alitalo K
    Curr Top Microbiol Immunol; 1999; 237():85-96. PubMed ID: 9893347
    [No Abstract]   [Full Text] [Related]  

  • 53. Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development.
    Partanen J; Puri MC; Schwartz L; Fischer KD; Bernstein A; Rossant J
    Development; 1996 Oct; 122(10):3013-21. PubMed ID: 8898215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.
    Puri MC; Rossant J; Alitalo K; Bernstein A; Partanen J
    EMBO J; 1995 Dec; 14(23):5884-91. PubMed ID: 8846781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis.
    Loughna S; Sato TN
    Mol Cell; 2001 Jan; 7(1):233-9. PubMed ID: 11172728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging issues in receptor protein tyrosine phosphatase function: lifting fog or simply shifting?
    Petrone A; Sap J
    J Cell Sci; 2000 Jul; 113 ( Pt 13)():2345-54. PubMed ID: 10852814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Switched at birth: a new family for PECAM-1.
    Newman PJ
    J Clin Invest; 1999 Jan; 103(1):5-9. PubMed ID: 9884328
    [No Abstract]   [Full Text] [Related]  

  • 58. Receptor protein tyrosine phosphatases: involvement in cell-cell interaction and signaling.
    Zondag GC; Moolenaar WH
    Biochimie; 1997 Sep; 79(8):477-83. PubMed ID: 9451448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leptin signalling.
    Sweeney G
    Cell Signal; 2002 Aug; 14(8):655-63. PubMed ID: 12020765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptor protein tyrosine kinases and phosphatases.
    Hunter T; Lindberg RA; Middlemas DS; Tracy S; van der Geer P
    Cold Spring Harb Symp Quant Biol; 1992; 57():25-41. PubMed ID: 1339664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.